The Patent Finder

Antibodies That Bind Human Protein Tyrosine Phosphatase Beta (HPTPBETA)

Eyepoint, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 60/790,506, filed Apr 7, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,926,367ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
In force
 · High confidence
Eyepoint, Inc.In force
High confidence
US 11,814,425ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
In force
 · Medium confidence
Eyepoint, Inc.In force
Medium confidence
US 8,524,235Method for Treating Coronary Artery Disease Using Antibody Binding Human Protein Tyrosine Phosphatase Beta(HPTPbeta)
In force
 · High confidence
Eyepoint, Inc.In force
High confidence
US 7,973,142Antibodies That Bind Human Protein Tyrosine Phosphatase Beta (HPTPBETA)
In force
 · High confidence
Eyepoint, Inc.In force
High confidence
Application 13/958,990ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES TEHREOF
Abandoned
Abandoned Mar 1, 2017
Eyepoint Pharmaceuticals, Inc.AbandonedAbandoned Mar 1, 2017
Application 15/894,442ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
Abandoned
Abandoned Jun 3, 2020
Eyepoint Pharmaceuticals, Inc.AbandonedAbandoned Jun 3, 2020
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Eyepoint, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited